United States Renal Cell Carcinoma (RCC) Market 2014-2019 & 2024: Treatment Options, Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales, Market Shares

News provided by

Jul 11, 2019, 18:45 ET

DUBLIN, July 11, 2019 /PRNewswire/ -- The "US Renal Cell Carcinoma Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

US Renal Cell Carcinoma Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Renal Cell Carcinoma pipeline products, Renal Cell Carcinoma epidemiology, Renal Cell Carcinoma market valuations and forecast, Renal Cell Carcinoma drugs sales and competitive landscape in the US.

The research is classified into seven sections - Renal Cell Carcinoma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

Renal Cell Carcinoma pipeline: Find out the products in clinical trials for the treatment of Renal Cell Carcinoma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
Renal Cell Carcinoma epidemiology: Find out the number of patients diagnosed (prevalence) with Renal Cell Carcinoma in the US
Renal Cell Carcinoma drugs: Identify key products marketed and prescribed for Renal Cell Carcinoma in the US, including trade name, molecule name, and company
Renal Cell Carcinoma drugs sales: Find out the sales revenues of Renal Cell Carcinoma drugs in the US
Renal Cell Carcinoma market valuations: Find out the market size for Renal Cell Carcinoma drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
Renal Cell Carcinoma drugs market share: Find out the market shares for key Renal Cell Carcinoma drugs in the US

Benefits of this Research

Support monitoring and reporting national Renal Cell Carcinoma market analysis and sales trends
Track competitor drugs sales and market share in the US Renal Cell Carcinoma market
Track competitive developments in Renal Cell Carcinoma market and present key issues and learnings
Synthesize insights for Renal Cell Carcinoma market and products to drive business performance
Answer key business questions about the Renal Cell Carcinoma market
Evaluate commercial market opportunity assessment, positioning, and segmentation for Renal Cell Carcinoma products
Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Renal Cell Carcinoma Treatments
2) Renal Cell Carcinoma Pipeline
3) US Renal Cell Carcinoma Epidemiology
4) Marketed Drugs for Renal Cell Carcinoma in US
5) US Renal Cell Carcinoma Market Size and Forecast
6) US Renal Cell Carcinoma Products Sales and Forecast
7) US Renal Cell Carcinoma Market Competitive Landscape
8) Methodology

List of Tables
1. Renal Cell Carcinoma Phase 3 Clinical Trials, 2019
2. Renal Cell Carcinoma Phase 2 Clinical Trials, 2019
3. Renal Cell Carcinoma Phase 1 Clinical Trials, 2019
4. Renal Cell Carcinoma Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Renal Cell Carcinoma, US, 2018
6. Renal Cell Carcinoma Market Size and Forecast ($), US, 2014 - 2024
7. Renal Cell Carcinoma Product Sales ($), US, 2014 - 2024

List of Figures
1. Renal Cell Carcinoma Epidemiology, US, 2014 - 2024
2. Renal Cell Carcinoma Market Size and Forecast ($), US, 2014 - 2024
3. Renal Cell Carcinoma Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/ys9ph8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets